Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

October 31, 2002

Study Completion Date

October 31, 2002

Conditions
Carcinoma, Non-Small-Cell LungLung Neoplasms
Interventions
DRUG

Investigational drug

Trial Locations (12)

40202

Research Center, Louisville

48109

Research Center, Ann Arbor

75390

Research Center, Dallas

76012

Research Center, Arlington

90048

Research Center, Los Angeles

92270

Research Center, Rancho Mirage

94704

Research Center, Berkeley

94904-2007

Research Center, Greenbrae

60637-1463

Research Center, Chicago

01583

Research Center, West Boylston

03756

Research Center, Lebanon

37232-6868

Research Center, Nashville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00034957 - Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter